ECSP22003856A - Derivados de n-metil, n-(6-(metoxi)piridazin-3-il) amina como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticas - Google Patents
Derivados de n-metil, n-(6-(metoxi)piridazin-3-il) amina como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticasInfo
- Publication number
- ECSP22003856A ECSP22003856A ECSENADI20223856A ECDI202203856A ECSP22003856A EC SP22003856 A ECSP22003856 A EC SP22003856A EC SENADI20223856 A ECSENADI20223856 A EC SENADI20223856A EC DI202203856 A ECDI202203856 A EC DI202203856A EC SP22003856 A ECSP22003856 A EC SP22003856A
- Authority
- EC
- Ecuador
- Prior art keywords
- pyridazin
- methoxy
- methyl
- autotaxin
- atx
- Prior art date
Links
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 title abstract 4
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 title abstract 4
- 230000003176 fibrotic effect Effects 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 201000009594 Systemic Scleroderma Diseases 0.000 abstract 2
- 206010042953 Systemic sclerosis Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- FTIABAXDLCWYMS-UHFFFAOYSA-N 1-[6-[4-[[[6-[[6-(trifluoromethyl)pyridin-3-yl]methoxy]pyridazin-3-yl]amino]methyl]phenyl]-2,6-diazaspiro[3.3]heptan-2-yl]ethanone Chemical compound FC(C1=CC=C(C=N1)COC1=CC=C(N=N1)NCC1=CC=C(C=C1)N1CC2(CN(C2)C(C)=O)C1)(F)F FTIABAXDLCWYMS-UHFFFAOYSA-N 0.000 abstract 1
- YPWBPONDYDVMLX-UHFFFAOYSA-N 6-methoxypyridazin-3-amine Chemical class COC1=CC=C(N)N=N1 YPWBPONDYDVMLX-UHFFFAOYSA-N 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a derivados de N-metil, N-(6-(metoxi)piridazin-3-il) amina como moduladores de autotaxina (ATX) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticas tales como, por ejemplo, enfermedad pulmonar idiopática (IFF) o esclerosis sistémica (SSc). La presente descripción divulga la preparación de compuestos de ejemplo (por ejemplo, páginas 57 a 75; ejemplos 1.1 a 5) así como también datos biológicos relevantes de estos (por ejemplo, páginas 15 a 21, tablas 1 a 9). Un compuesto de ejemplo es, por ejemplo, 1-(6-(4-(((6-((6-(trifluorometilo)piridin-3-il)metoxi)piridazin-3-il)amino)metil)fenil)-2,6-diazaespiro[3.3]heptan-2-il)etan-1-ona (ejemplo 1.1).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19187617 | 2019-07-22 | ||
PCT/EP2020/070547 WO2021013830A1 (en) | 2019-07-22 | 2020-07-21 | N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (atx) modulators for the treatment of inflammatory airway or fibrotic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP22003856A true ECSP22003856A (es) | 2022-02-25 |
Family
ID=67438402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI20223856A ECSP22003856A (es) | 2019-07-22 | 2022-01-17 | Derivados de n-metil, n-(6-(metoxi)piridazin-3-il) amina como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticas |
Country Status (25)
Country | Link |
---|---|
US (2) | US11485727B2 (es) |
EP (2) | EP4364805A2 (es) |
JP (2) | JP2022541065A (es) |
KR (1) | KR20220038438A (es) |
CN (1) | CN114206876B (es) |
AR (1) | AR119453A1 (es) |
AU (1) | AU2020316643A1 (es) |
BR (1) | BR112021026887A2 (es) |
CA (1) | CA3145868A1 (es) |
CL (1) | CL2022000112A1 (es) |
CO (1) | CO2022000243A2 (es) |
CR (1) | CR20220022A (es) |
DK (1) | DK4003998T3 (es) |
DO (1) | DOP2022000008A (es) |
EC (1) | ECSP22003856A (es) |
FI (1) | FI4003998T3 (es) |
IL (1) | IL289788A (es) |
JO (1) | JOP20220012A1 (es) |
LT (1) | LT4003998T (es) |
MA (1) | MA56631B1 (es) |
MX (1) | MX2022000958A (es) |
PE (1) | PE20220964A1 (es) |
PT (1) | PT4003998T (es) |
TW (1) | TW202120492A (es) |
WO (1) | WO2021013830A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020089098A1 (en) | 2018-10-29 | 2020-05-07 | Boehringer Ingelheim International Gmbh | Novel pyridazines |
US11465982B2 (en) | 2019-07-22 | 2022-10-11 | Boehringer Ingelheim International Gmbh | Pyridazines |
KR102587919B1 (ko) * | 2022-07-22 | 2023-10-11 | 주식회사 넥스트젠바이오사이언스 | 신규한 헤테로사이클릭 화합물 및 이를 포함하는 오토탁신 저해용 약학 조성물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2007003580A1 (es) * | 2006-12-11 | 2009-03-27 | Boehringer Ingelheim Int | Compuestos derivados de piridazina, antagonistas de mch; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos metabolicos y/o trastornos alimentarios como obesidad, bulimia, anorexia, hiperfagia, diabetes. |
TW200944520A (en) * | 2008-01-29 | 2009-11-01 | Glaxo Group Ltd | Spiro compounds as NPY Y5 receptor antagonists |
EP2771325B1 (en) * | 2011-10-28 | 2017-06-28 | Inhibitaxin Limited | Pyridazine derivatives useful in therapy |
PT2970255T (pt) | 2013-03-14 | 2017-09-05 | Galapagos Nv | Compostos e as suas composições farmacêuticas para o tratamento de doenças inflamatórias |
US9796719B2 (en) | 2013-06-19 | 2017-10-24 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
GB201503141D0 (en) * | 2015-02-03 | 2015-04-08 | Fosbel Inc | Integral self-supporting refractory checker brick modules for glass furnace regenerator structures, and methods of forming same |
GB201603745D0 (en) * | 2016-03-04 | 2016-04-20 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis |
WO2017192304A1 (en) * | 2016-05-02 | 2017-11-09 | Inception 1, Inc. | Arylcarboxamides and uses thereof |
KR101798840B1 (ko) * | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
BR112020027051A2 (pt) * | 2018-07-27 | 2021-03-30 | Mitsubishi Tanabe Pharma Corporation | Derivados de piridina 3,5-dissubstituída e piridazina 3,5-dissubstituída e uso farmacêutico dos mesmos |
WO2020089098A1 (en) | 2018-10-29 | 2020-05-07 | Boehringer Ingelheim International Gmbh | Novel pyridazines |
US11465982B2 (en) | 2019-07-22 | 2022-10-11 | Boehringer Ingelheim International Gmbh | Pyridazines |
KR20220035950A (ko) | 2019-07-22 | 2022-03-22 | 베링거 인겔하임 인터내셔날 게엠베하 | 염증성 기도 질환 또는 섬유성 질환의 치료를 위한 오토탁신 (atx) 조절제로서의 n-메틸, n-(6-(메톡시)피리다진-3-일) 아민 유도체 |
-
2020
- 2020-07-20 US US16/932,882 patent/US11485727B2/en active Active
- 2020-07-21 DK DK20743687.4T patent/DK4003998T3/da active
- 2020-07-21 EP EP24157589.3A patent/EP4364805A2/en active Pending
- 2020-07-21 EP EP20743687.4A patent/EP4003998B1/en active Active
- 2020-07-21 AR ARP200102049A patent/AR119453A1/es unknown
- 2020-07-21 MX MX2022000958A patent/MX2022000958A/es unknown
- 2020-07-21 PT PT207436874T patent/PT4003998T/pt unknown
- 2020-07-21 JP JP2022503996A patent/JP2022541065A/ja not_active Ceased
- 2020-07-21 MA MA56631A patent/MA56631B1/fr unknown
- 2020-07-21 AU AU2020316643A patent/AU2020316643A1/en active Pending
- 2020-07-21 CA CA3145868A patent/CA3145868A1/en active Pending
- 2020-07-21 CR CR20220022A patent/CR20220022A/es unknown
- 2020-07-21 TW TW109124572A patent/TW202120492A/zh unknown
- 2020-07-21 JO JOP/2022/0012A patent/JOP20220012A1/ar unknown
- 2020-07-21 CN CN202080051863.5A patent/CN114206876B/zh active Active
- 2020-07-21 KR KR1020227005957A patent/KR20220038438A/ko unknown
- 2020-07-21 WO PCT/EP2020/070547 patent/WO2021013830A1/en active Application Filing
- 2020-07-21 PE PE2022000105A patent/PE20220964A1/es unknown
- 2020-07-21 BR BR112021026887A patent/BR112021026887A2/pt unknown
- 2020-07-21 FI FIEP20743687.4T patent/FI4003998T3/fi active
- 2020-07-21 LT LTEPPCT/EP2020/070547T patent/LT4003998T/lt unknown
-
2022
- 2022-01-12 IL IL289788A patent/IL289788A/en unknown
- 2022-01-14 CO CONC2022/0000243A patent/CO2022000243A2/es unknown
- 2022-01-17 EC ECSENADI20223856A patent/ECSP22003856A/es unknown
- 2022-01-17 CL CL2022000112A patent/CL2022000112A1/es unknown
- 2022-01-19 DO DO2022000008A patent/DOP2022000008A/es unknown
- 2022-09-23 US US17/934,625 patent/US20230100516A1/en active Pending
-
2023
- 2023-04-20 JP JP2023069392A patent/JP2023116436A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MA56631B1 (fr) | 2024-05-31 |
EP4003998B1 (en) | 2024-03-27 |
CN114206876B (zh) | 2024-05-14 |
KR20220038438A (ko) | 2022-03-28 |
CO2022000243A2 (es) | 2022-01-17 |
JP2023116436A (ja) | 2023-08-22 |
CL2022000112A1 (es) | 2022-10-21 |
BR112021026887A2 (pt) | 2022-04-26 |
PE20220964A1 (es) | 2022-06-10 |
FI4003998T3 (fi) | 2024-04-24 |
CN114206876A (zh) | 2022-03-18 |
US11485727B2 (en) | 2022-11-01 |
IL289788A (en) | 2022-03-01 |
CR20220022A (es) | 2022-03-02 |
AU2020316643A1 (en) | 2022-02-17 |
EP4003998A1 (en) | 2022-06-01 |
US20210024495A1 (en) | 2021-01-28 |
DK4003998T3 (da) | 2024-06-10 |
CA3145868A1 (en) | 2021-01-28 |
JP2022541065A (ja) | 2022-09-21 |
PT4003998T (pt) | 2024-04-26 |
AR119453A1 (es) | 2021-12-22 |
WO2021013830A1 (en) | 2021-01-28 |
US20230100516A1 (en) | 2023-03-30 |
EP4364805A2 (en) | 2024-05-08 |
JOP20220012A1 (ar) | 2023-01-30 |
DOP2022000008A (es) | 2022-03-15 |
MX2022000958A (es) | 2022-02-14 |
TW202120492A (zh) | 2021-06-01 |
LT4003998T (lt) | 2024-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2022000008A (es) | Derivados de n-metil, n-(6-(metoxi)piridazin-3-il) amina como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticas | |
CL2022000111A1 (es) | Derivados de n-(6-metoxi)pirizadin-3-il) amina, n-metilo como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vías respiratorias o fibróticas | |
NZ592685A (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
MX2019008690A (es) | Compuestos espiro heterociclicos como inhibidores de magl. | |
CL2004001366A1 (es) | Compuestos derivados de 2-(6-amino-piridin-2-il)-2-hidroxietilamino sustituidos, agonistas b2-adrenoceptores; procedimiento de preparacion; composicion farmaceutica; composicion farmaceutica y uso del compuesto en el tratamiento de asma, bronquitis c | |
MEP43308A (en) | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof | |
CY1114702T1 (el) | Νεοι εναnτιομερως καθαροι βητα αγωνιστες, μεθοδος για την παραγωγη τους και χρηση αυτων ως φαρμακων | |
SI2743266T1 (en) | Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis | |
BRPI0514750A (pt) | derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase | |
BR112022001176A2 (pt) | Derivados de 1-(6-(metoxi)piridazin-3-il)ciclopropano-1-carboxamida como moduladores de autotaxina (atx) para o tratamento de doenças inflamatórias das vias aéreas | |
BR112014005468A2 (pt) | derivados de aminopiridina para uso como moduladores de atividade quinase | |
EA025158B9 (ru) | Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения | |
MX2019008626A (es) | Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-ilcarbamato como inhibidores de monoacilglicerol lipasa (magl). | |
UY28896A1 (es) | Formulaciones en polvo para la inhalación , las cuales contienen beta-agonistas enantioméricamente puros | |
UY27039A1 (es) | Formas de sal de amida de acido 3-(4-bromo-2,6-difluoro-benciloxi)-5-(3-(pirrolidin-1-ilbutil)ureido)isotiazol-4-carboxilico y métodos de producción | |
CO6251286A2 (es) | Sales amino del acido [4, 6-bis(dimetilamino)-2-(4-(4-trifluorometil)benzamido)bencil)pirimidin-5-il]acetico, composiciones farmaceuticas de las mismas y sus usos para el tratamiento de enfermedades mediadas por crth-2 | |
CY1109647T1 (el) | Φαρμακευτικα σκευασματα στερεας μορφης που περιεχουν διασυρεϊνη και μελοξικαμη | |
BR112018074439A2 (pt) | tratamento para doença de parkinson | |
BR112015004511A8 (pt) | Derivados de pirazol carboxamida como moduladores de taar para uso no tratamento de diversas desordens, tais como depressão, diabetes e doença de parkinson | |
EA201100422A1 (ru) | (фенил)амиды 7-(пиперазин-1-илметил)-1h-индол-2-карбоновой кислоты и родственные соединения в качестве ингибиторов мар-киназы p38 для лечения заболеваний дыхательных путей | |
UY29078A1 (es) | Amidas del ácido 5 y 6-aminoalquil indol-2-carboxílico 3-sustituidas y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon) | |
BRPI0913736A2 (pt) | Composto, processo para a preparação do composto, composição farmacêutica e método para o tratamento de uma desordem do sistema nervoso central | |
EA200970496A1 (ru) | Соединения 2-алкилиндазола для лечения некоторых расстройств цнс | |
EA201990188A1 (ru) | Производные 5,7-дигидропирролопиридина | |
PL407364A1 (pl) | Nowe pochodne naftalenu, sposób ich wytwarzania i zastosowanie, nowe związki pośrednie do wytwarzania nowych pochodnych naftalenu, nowe fotosensybilizatory do procesów fotoinicjowanej polimeryzacji kationowej oraz nowe systemy fotoinicjujące |